Seoul National University Airway Registry
Airway Registry for Chronic Airway Diseases
1 other identifier
observational
800
1 country
3
Brief Summary
This is a multicenter, prospective observational cohort study, in which patients with chronic airway diseases including chronic obstructive pulmonary disease(COPD), asthma, asthma-COPD overlap syndrome (ACOS) will be recruited.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2011
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
December 19, 2014
CompletedFirst Posted
Study publicly available on registry
August 19, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2031
ExpectedAugust 19, 2015
August 1, 2015
10.3 years
December 19, 2014
August 17, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Death (time to death)
death from any cause, death from COPD-specific cause, death from CVD, malignancy
upto 20 years
Secondary Outcomes (1)
post-bronchodilator FEV1 change rates
upto 20 years (at least 3 years)
Other Outcomes (2)
Time to 1st exacerbation (definition of exacerbation is described below)
upto 20 years
Annual rate of exacerbation (definition of exacerbation is described below)
upto 20 years
Study Arms (1)
No predefined subgroups
Eligibility Criteria
COPD Asthma ACOS Bronchiectasis TB-destroyed lung Other chronic airway diseases
You may qualify if:
- Postbronchodilator FEV1/FVC \< 0.7 AND chronic respiratory symptom
You may not qualify if:
- Asthma
- Never smoker or \<5PY of smoking history AND Recurrent episodes of asthma symptoms (wheezing, dyspnea, chest tightness, cough) AND (either Positive BDR OR positive metacholine/mannitol/exercise provocation test)
- ACOS
- COPD AND Asthma (regardless of smoking status)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 463-707, South Korea
Seoul National University Hospital
Seoul, 110-744, South Korea
Seoul Metropolitan Government-Seoul National University Boramae Medical Center
Seoul, 156-707, South Korea
Related Publications (2)
Jo YS, Park S, Kim DK, Yoo CG, Lee CH. The cutoff point of clinical chronic obstructive pulmonary disease questionnaire for more symptomatic patients. BMC Pulm Med. 2018 Feb 27;18(1):38. doi: 10.1186/s12890-018-0601-0.
PMID: 29482616DERIVEDJo YS, Lee J, Yoon HI, Kim DK, Yoo CG, Lee CH. Different prevalence and clinical characteristics of asthma-chronic obstructive pulmonary disease overlap syndrome according to accepted criteria. Ann Allergy Asthma Immunol. 2017 Jun;118(6):696-703.e1. doi: 10.1016/j.anai.2017.04.010.
PMID: 28583262DERIVED
Biospecimen
Blood (whole blood, serum, plasma, buffy coat) Urine
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Chul-Gyu Yoo, M.D.
Seoul National University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
December 19, 2014
First Posted
August 19, 2015
Study Start
September 1, 2011
Primary Completion
December 1, 2021
Study Completion (Estimated)
December 1, 2031
Last Updated
August 19, 2015
Record last verified: 2015-08